Management of immune-related adverse events

被引：0
|
作者：
Princk, Marika Henriette [1 ,2 ]
Pervan, Mascha [3 ]
Riedl, Joerg [1 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Univ Canc Ctr Schleswig Holstein, Campus Lubeck, Lubeck, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Geburtshilfe, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany
[3] Univ Klinikum Munster UKM, Klin Gynakol & Geburtshilfe, Munster, Germany
来源：
UROLOGIE | 2025年
关键词：
Immune checkpoint inhibitors; Pembrolizumab; Atezolizumab; Corticosteroids; Autoimmunity;
D O I：
10.1007/s00120-024-02517-x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
With the implementation of immunotherapy, a completely new, broad spectrum of side effects has emerged in oncology-the immune-related adverse events (irAEs). Their management differs greatly from that of classic cytotoxic side effects and is based primarily on corticosteroids, immunomodulatory agents, and treatment interruptions. Whereas some events are low grade and reversible, others can be severe and lead to permanent disorders or even death. Therefore, early recognition and treatment in the context of interdisciplinary side effects management is critical for patients' safety, prognosis, and quality of life.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Immune-Related Adverse Events: Development of a Pilot Immune-Related Adverse Events Clinic for Expedited and Effective Patient Care
    Reid, Pankti
    Jan, Reem
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Javaid, Anadil
    Bennett, Catherine
    Rao, Aparna
    Spain, Lavinia
    PHARMACEUTICAL MEDICINE, 2024, 38 (01) : 25 - 38
  • [23] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Anadil Javaid
    Catherine Bennett
    Aparna Rao
    Lavinia Spain
    Pharmaceutical Medicine, 2024, 38 : 25 - 38
  • [24] Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
    Olsen, T. Anders
    Zhuang, Tony Zibo
    Caulfield, Sarah
    Martini, Dylan J.
    Brown, Jacqueline T.
    Carthon, Bradley C.
    Kucuk, Omer
    Harris, Wayne
    Bilen, Mehmet Asim
    Nazha, Bassel
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events
    Brongiel, Samantha
    Rychalsky, Kristen L.
    Luon, Darren
    Johnson, Aubrey R.
    Price, Christina
    Abdelghany, Osama
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (02) : 148 - 155
  • [26] Management of immune-related adverse events (irAEs) - what needs to be respected?
    Thomssen, Christoph
    GYNAKOLOGE, 2022, 55 (05): : 344 - 350
  • [27] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Eli P. Darnell
    Meghan J. Mooradian
    Erez N. Baruch
    Melis Yilmaz
    Kerry L. Reynolds
    Current Oncology Reports, 2020, 22
  • [28] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Darnell, Eli P.
    Mooradian, Meghan J.
    Baruch, Erez N.
    Yilmaz, Melis
    Reynolds, Kerry L.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [29] Atherosclerotic Progression Is Related to Immune-Related Adverse Events
    Kurozumi, Atsumasa
    Sakamoto, Kayo
    Nakagawa, Takashi
    Matsunaga, Futoshi
    Shimomura, Akihiko
    Shimizu, Chikako
    Hara, Hisao
    Hiroi, Yukio
    INTERNATIONAL HEART JOURNAL, 2022, 63 (02) : 293 - 298
  • [30] Clinical assessment of immune-related adverse events
    Sosa, Aaron
    Lopez Cadena, Esther
    Simon Olive, Cristina
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
12345